Your browser doesn't support javascript.
Characteristics associated with COVID-19 vaccine uptake among adults aged 50 years and above in England (8 December 2020-17 May 2021): a population-level observational study.
Tessier, Elise; Rai, Yuma; Clarke, Eleanor; Lakhani, Anissa; Tsang, Camille; Makwana, Ashley; Heard, Heather; Rickeard, Tim; Lakhani, Shreya; Roy, Partho; Edelstein, Michael; Ramsay, Mary; Lopez-Bernal, Jamie; White, Joanne; Andrews, Nick; Campbell, Colin N J; Stowe, Julia.
  • Tessier E; Immunisation and Countermeasures Division, Public Health England, London, UK elise.tessier@phe.gov.uk.
  • Rai Y; Immunisation and Countermeasures Division, Public Health England, London, UK.
  • Clarke E; Immunisation and Countermeasures Division, Public Health England, London, UK.
  • Lakhani A; Immunisation and Countermeasures Division, Public Health England, London, UK.
  • Tsang C; Immunisation and Countermeasures Division, Public Health England, London, UK.
  • Makwana A; Vaccines and Countermeasures Division, Public Health England, London, UK.
  • Heard H; Health Intelligence Division, Health Improvement Directorate, Public Health England, York, UK.
  • Rickeard T; Vaccines and Countermeasures Division, Public Health England, London, UK.
  • Lakhani S; Immunisation and Countermeasures Division, Public Health England, London, UK.
  • Roy P; Immunisation and Countermeasures Division, Public Health England, London, UK.
  • Edelstein M; Faculty of Medicine, Bar-Ilan University, Safed, Israel.
  • Ramsay M; Immunisation and Countermeasures Division, Public Health England, London, UK.
  • Lopez-Bernal J; Immunisation and Countermeasures Division, Public Health England, London, UK.
  • White J; Immunisation and Countermeasures Division, Public Health England, London, UK.
  • Andrews N; Immunisation and Countermeasures Division, Public Health England, London, UK.
  • Campbell CNJ; Immunisation and Countermeasures Division, Public Health England, London, UK.
  • Stowe J; Immunisation and Countermeasures Division, Public Health England, London, UK.
BMJ Open ; 12(3): e055278, 2022 03 01.
Article in English | MEDLINE | ID: covidwho-1723800
ABSTRACT

OBJECTIVE:

To determine characteristics associated with COVID-19 vaccine coverage among individuals aged 50 years and above in England since the beginning of the programme.

DESIGN:

Observational cross-sectional study assessed by logistic regression and mean prevalence margins.

SETTING:

COVID-19 vaccinations delivered in England from 8 December 2020 to 17 May 2021.

PARTICIPANTS:

30 624 257/61 967 781 (49.4%) and 17 360 045/61 967 781 (28.1%) individuals in England were recorded as vaccinated in the National Immunisation Management System with a first dose and a second dose of a COVID-19 vaccine, respectively.

INTERVENTIONS:

Vaccination status with COVID-19 vaccinations. MAIN OUTCOME

MEASURES:

Proportion, adjusted ORs and mean prevalence margins for individuals not vaccinated with dose 1 among those aged 50-69 years and dose 1 and 2 among those aged 70 years and above.

RESULTS:

Of individuals aged 50 years and above, black/African/Caribbean ethnic group was the least likely of all ethnic groups to be vaccinated with dose 1 of the COVID-19 vaccine. However, of those aged 70 years and above, the odds of not having dose 2 was 5.53 (95% CI 5.42 to 5.63) and 5.36 (95% CI 5.29 to 5.43) greater among Pakistani and black/African/Caribbean compared with white British ethnicity, respectively. The odds of not receiving dose 2 was 1.18 (95% CI 1.16 to 1.20) higher among individuals who lived in a care home compared with those who did not. This was the opposite to that observed for dose 1, where the odds of being unvaccinated was significantly higher among those not living in a care home (0.89 (95% CI 0.87 to 0.91)).

CONCLUSIONS:

We found that there are characteristics associated with low COVID-19 vaccine coverage. Inequalities, such as ethnicity are a major contributor to suboptimal coverage and tailored interventions are required to improve coverage and protect the population from SARS-CoV-2.
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Adult / Aged / Humans / Middle aged Country/Region as subject: Europa Language: English Journal: BMJ Open Year: 2022 Document Type: Article Affiliation country: Bmjopen-2021-055278

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Adult / Aged / Humans / Middle aged Country/Region as subject: Europa Language: English Journal: BMJ Open Year: 2022 Document Type: Article Affiliation country: Bmjopen-2021-055278